Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
38M
-
Shares change
-
+2.06M
-
Total reported value, excl. options
-
$901M
-
Value change
-
+$56.4M
-
Put/Call ratio
-
0.5
-
Number of buys
-
85
-
Number of sells
-
-63
-
Price
-
$23.70
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q1 2021
178 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q1 2021.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38M shares
.
Largest 10 shareholders include BlackRock Inc. (5.89M shares), JANUS HENDERSON GROUP PLC (4.08M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.43M shares), Rubric Capital Management LP (2.42M shares), VANGUARD GROUP INC (2.19M shares), Camber Capital Management LP (2M shares), RENAISSANCE TECHNOLOGIES LLC (1.27M shares), STATE STREET CORP (1.1M shares), PERCEPTIVE ADVISORS LLC (978K shares), and Invesco Ltd. (931K shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.